Các yếu tố liên quan đến chẩn đoán muộn ung thư vú ở phụ nữ tại Togo, Châu Phi hạ Sahara

Springer Science and Business Media LLC
Tchin Darré1, Lantam Tchandikou1, Panakinao Simgban1, Mayi Bombone1, Toukilnan Djiwa1, B. N’timon2, Bagassam Mézéwè Sama1, Ayoko Ketevi3, Baguilane Douaguibe3, Bingo K. N’Bortche3, Yao Seddoh3, Mazamaesso Tchaou2, Gado Napo‐Koura1
1Department of Pathology, University Teaching Hospital of Lomé, Lomé, Togo
2Department of Imaging, University Teaching Hospital of Lomé and Kara, Lomé, Togo
3Department Obstetrics and Gynecology, University Teaching Hospital of Lomé, Lomé, Togo

Tóm tắt

Tóm tắtHoàn cảnhUng thư vú là loại ung thư được chẩn đoán thường xuyên nhất ở phụ nữ trên toàn thế giới. Mục tiêu của nghiên cứu này là xác định các yếu tố liên quan đến việc chẩn đoán muộn ung thư vú ở phụ nữ Togo.Phương phápChúng tôi đã thực hiện một nghiên cứu cắt ngang tiềm năng với mục đích mô tả và phân tích về các trường hợp ung thư vú ở phụ nữ trong năm 2021, tại Togo. Các bệnh nhân được đưa vào nghiên cứu này là những phụ nữ theo dõi tại khoa sản phụ khoa với bệnh ung thư vú giai đoạn III và IV.Kết quảChúng tôi đã bao gồm 62 trường hợp ung thư vú. Tuổi trung bình của các bệnh nhân là 38.6 ± 12.5 năm, với giới hạn từ 17 đến 76 năm. Khối u vú là lý do tư vấn phổ biến nhất, chiếm 75.8% các trường hợp. Các loại mô học được chẩn đoán bao gồm carcinoma xâm lấn không đặc hiệu (58; 93.55%), carcinoma nhầy (3; 4.84%) và carcinoma tế bào gian đới (1; 1.61%). Về giai đoạn của ung thư, 43 bệnh nhân ở giai đoạn III (69.4%) và 19 bệnh nhân ở giai đoạn IV (30.6%).Trong phân tích đa biến, các yếu tố liên quan đến việc chẩn đoán muộn ung thư vú bao gồm: sợ hãi khi chẩn đoán (aOR = 1.29;p = 0.0014), khoảng thời gian chẩn đoán lâu (aOR = 2.62;p = 0.0001) và không thực hiện kiểm tra tự khám ngực (aOR = 1.68;p = 0.0022).Kết luậnSự sợ hãi khi chẩn đoán, sự vắng mặt của việc tự kiểm tra vú và việc sử dụng điều trị truyền thống cùng tự điều trị với ý định ban đầu là những yếu tố trọng yếu dẫn đến việc chẩn đoán muộn ung thư vú. Cần triển khai các chiến lược ở cấp quốc gia để tác động đến những yếu tố này nhằm chẩn đoán sớm ung thư vú.

Từ khóa


Tài liệu tham khảo

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

Adeloye D, Sowunmi OY, Jacobs W, David RA, Adeosun AA, Amuta AO, et al. Estimating the incidence of breast cancer in Africa: a systematic review and meta-analysis. J Glob Health. 2018;8(1):010419.

Adeloye D, Sowunmi OY, Jacobs W, David RA, Adeosun AA, Amuta AO, et al. J Glob Health. 2018;8(1):010419. https://doi.org/10.7189/jogh.08.010419. PMID: 29740502.

Joko-Fru WY, Miranda-Filho A, Soerjomataram I, Egue M, Akele-Akpo MT, da N’ G, et al. Breast cancer survival in sub-Saharan Africa by age, stage at diagnosis and human development index: a population-based registry study. Int J Cancer. 2020;146(5):1208–18.

Lukong KE, Ogunbolude Y, Kamdem JP. Breast cancer in Africa: prevalence, treatment options, herbal medicines, and socioeconomic determinants. Breast Cancer Res Treat. 2017;166(2):351–65.

Pace LE, Shulman LN. Breast cancer in Sub-Saharan Africa: challenges and opportunities to reduce mortality. Oncologist. 2016;21(6):739–44. https://doi.org/10.1634/theoncologist.2015-0429. Epub 2016 Apr 18PMID: 27091419.

Djiwa T, Koui B, Simgban P, Mézéwè Sama B, Bombonne M, Doukouré B, Darré T. Histo-molecular profile of breast cancer in young women in Togo. Clin Pathol. 2022;15:2632010X221112452. https://doi.org/10.1177/2632010X221112452.

Jedy-Agba E, McCormack V, Adebamowo C, Dos-Santos-Silva I. Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2016;4(12):e923–35. https://doi.org/10.1016/S2214-109X(16)30259-5.

Darre T, Kpatcha TM, Bagny A, Maneh N, Gnandi-Piou F, Tchangai B, et al. Descriptive Epidemiology of Cancers in Togo from 2009 to 2016. Asian Pac J Cancer Prev. 2017;18(12):3407–11. https://doi.org/10.22034/APJCP.2017.18.12.3407. PMID: 29286611.

Darré T, Tchaou M, Djiwa T, Douaguibe B, Bassowa A, Adani-Ifé S, et al. Breast cancer in togolese women: imaging and clinicopathological findings. Breast Cancer (Auckl). 2021;15:11782234211020242. https://doi.org/10.1177/11782234211020242.

Darre T, Tchaou M, Djiwa T, Simgban P, Amavi AK, N’Timon B, et al. Male breast cancer in Togo: imaging and clinicopathological findings. Int J Breast Cancer. 2020;2020:3056067. https://doi.org/10.1155/2020/3056067.

Darré T, Tchaou M, Folligan K, Amadou A, N’Timon B, Sonhaye L, et al. Breast cancer cases of female patients under 35 years of age in Togo: a series of 158 cases. Mol Clin Oncol. 2017;7(6):1125–9. https://doi.org/10.3892/mco.2017.1461.

Adani-Ifè A, Amégbor K, Doh K, Darré T. Breast cancer in togolese women: immunohistochemistry subtypes. BMC Womens Health. 2020;20(1):261. https://doi.org/10.1186/s12905-020-01130-2. PMID: 33228656.

Hortobagyi GN, Connolly JL, D’Orsi CJ, Edge SB, Mittendorf EA, et al. Breast. In: Amin MB, Edge S, Greene F, et al, editors; American Joint Committee on Cancer. AJCC cancer staging manual. 8th ed. New York, NY: Springer. 2017.

Balekouzou A, Yin P, Pamatika CM, Bishwajit G, Nambei SW, Djeintote M, et al. Epidemiology of breast cancer: retrospective study in the Central African Republic. Public Health. 2016;16(1):1230.

Ly M, Antoine M, André F, Callard P, Bernaudin JF, Diallo DA. Breast cancer in sub-Saharan African women: review. Bull Cancer. 2011;98:797–806.

Aman NA, Doukoure B, Koffi KD, Koui BS, Traore ZC, Kouyate M, Effi AB. HER2 overexpression and correlation with other significant clinicopathologic parameters in Ivorian breast cancer women. BMC Clin Pathol. 2019;19:1.

Akuoko CP, Armah E, Sarpong T, Quansah DY, Amankwaa I, Boateng D. Barriers to early presentation and diagnosis of breast cancer among African women living in sub-Saharan Africa. PLoS One. 2017;12(2):e0171024. https://doi.org/10.1371/journal.pone.0171024.

Azubuike SO, Muirhead C, Hayes L, McNally R. Rising global burden of breast cancer: the case of sub-Saharan Africa (with emphasis on Nigeria) and implications for regional development: a review. World J Surg Oncol. 2018;16(1):63.

Mutebi M, Anderson BO, Duggan C, Adebamowo C, Agarwal G, Ali Z, et al. Breast cancer treatment: a phased approach to implementation. Cancer. 2020;126(Suppl 10):2365–78. https://doi.org/10.1002/cncr.32910.

Aziato L, Clegg-Lamptey JN. Breast cancer diagnosis and factors influencing treatment decisions in Ghana. Health Care Women Int. 2015;36(5):543–57.

Agodirin O, Olatoke S, Rahman G, Kolawole O, Oguntola S, Olasehinde O, et al. Determinants of late detection and advanced-stage diagnosis of breast cancer in Nigeria. PLoS One. 2021;16(11):e0256847. https://doi.org/10.1371/journal.pone.0256847.

Darré T, Amegbor K, Sonhayé L, Kouyate M, Aboubarak A, N’Timo B, et al. Histo-epidemiological profile of breast cancer: about 450 cases seen at the university hospital of Lome. Méd Afr Noire. 2013;60:53–8.

Darre T, Djiwa T, N’Timon B, Simgban P, Tchaou M, Napo-Koura G. Breast primary angiosarcoma: a clinicopathologic and imaging study of a series cases. Breast Cancer (Auckl). 2022;16:11782234221086726. https://doi.org/10.1177/11782234221086726.

Tchaou M, Darre T, Amavi AK, Kanassoua KK, N’Timon B, Sonhaye L, et al. Breast abscessed cancer in nonlactating women in tropical environment: radiological, bacteriological, and anatomopathological features about 3 cases. Case Rep Radiol. 2017;2017:1639847. https://doi.org/10.1155/2017/1639847.

Luyeye Mvila G, Postema S, Marchal G, Van Limbergen E, Verdonck F, Matthijs G, et al. From the set-up of a screening program of breast cancer patients to the identification of the first BRCA mutation in the DR Congo. BMC Public Health. 2014;14:759. https://doi.org/10.1186/1471-2458-14.

Luyeye Mvila G, Batalansi D, Praet M, Marchal G, Laenen A, Christiaens MR, et al. Prognostic features of breast cancer differ between women in the Democratic Republic of Congo and Belgium. Breast. 2015;24(5):642–8.

Aman NA, Doukoure B, Koffi KD, Koui BS, Traore ZC, Kouyate M, et al. Immunohistochemical evaluation of Ki-67 and comparison with clinicopathologic factors in breast carcinomas. Asian Pac J Cancer Prev. 2019;20(1):73–9.

Effi AB, Aman NA, Koui BS, Koffi KD, Traore ZC, Kouyate M. Breast cancer molecular subtypes defined by ER/PR and HER2 status: association with clinicopathologic parameters in ivorian patients. Asian Pac J Cancer Prev. 2016;17(4):1973–8.

Effi AB, Aman NA, Koui BS, Koffi KD, Traoré ZC, Kouyate M. Immunohistochemical determination of estrogen and progesterone receptors in breast cancer: relationship with clinicopathologic factors in 302 patients in Ivory coast. BMC Cancer. 2017;17(1):115. https://doi.org/10.1186/s12885-017-3105-z. PMID: 28173783.

Darre T, Tchaou M, Djiwa T, Tcharié LE, Brun LV, Gbeasor-Komlanvi AF, et al. Breast cancer: knowledge, attitudes on risk factors and means of screening by medical students from Lomé Togo. Adv Breast Cancer Res. 2020;9:127–37.

Tesfaw A, Getachew S, Addissie A, Jemal A, Wienke A, Taylor L, Kantelhardt EJ. Late-stage diagnosis and associated factors among breast cancer patients in South and Southwest Ethiopia: a multicenter study. Clin Breast Cancer. 2021;21(1):e112–9. https://doi.org/10.1016/j.clbc.2020.08.011. Epub 2020 Oct 1PMID: 33536135.

Gebremariam A, Dereje N, Addissie A, Worku A, Assefa M, Abreha A, et al. Factors associated with late-stage diagnosis of breast cancer among women in Addis Ababa. Ethiopia Breast Cancer Res Treat. 2021;185(1):117–24. https://doi.org/10.1007/s10549-020-05919-5. Epub 2020 Sep 18PMID: 32948993.

Youngblood VM, Nyirenda R, Nyasosela R, Zuze T, Yang Y, Kudowa E, et al. Outcomes and prognostic factors for women with breast cancer in Malawi. Cancer Causes Control. 2020;31(4):393–402. https://doi.org/10.1007/s10552-020-01282-4. Epub 2020 Mar.

Moodley J, Walter FM, Scott SE, Mwaka AM. Towards timely diagnosis of symptomatic breast and cervical cancer in South Africa. S Afr Med J. 2018;108(10):803–4. https://doi.org/10.7196/SAMJ.2018.v108i10.13478. PMID: 30421705.

Tetteh DA, Faulkner SL. Sociocultural factors and breast cancer in sub-Saharan Africa: implications for diagnosis and management. Womens Health (Lond). 2016;12(1):147–56. https://doi.org/10.2217/whe.15.76. Epub 2016 Jan 12PMID: 26757491.

Ben Fatma L, Belaid I, Said N, Gahbiche S, Hochlef M, Chabchoub I, et al. What could be the reasons of late diagnosis of breast cancer in Tunisia? Tunis Med. 2018;96(10–11):665–71 PMID: 30746659.

Maghous A, Rais F, Ahid S, Benhmidou N, Bellahamou K, Loughlimi H, et al. Factors influencing diagnosis delay of advanced breast cancer in Moroccan women. BMC Cancer. 2016;16:356. https://doi.org/10.1186/s12885-016-2394-y.PMID:27268201FreePMC.

Agodirin O, Aremu I, Rahman G, Olatoke S, Olaogun J, Akande H, Romanoff A. Determinants of delayed presentation and advanced stage diagnosis of breast cancer in Africa: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2021;22(4):1007–17.

Toure M, Nguessan E, Bambara AT, Kouassi YK, Dia JM, Adoubi I. Factors linked to late diagnosis in breast cancer in Sub-Saharan Africa: case of Côte d’Ivoire. Gynecol Obstet Fertil. 2013;41(12):696–700. https://doi.org/10.1016/j.gyobfe.2013.08.019.

Aloulou S, El Mahfoudi A, El Omrani A, Khouchani M. Factors related to late diagnosis of breast cancer: experience of CHU Mohammed VI Marrakech. Pan Afr Med J. 2015;21:162. https://doi.org/10.11604/pamj.2015.21.162.4363.

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Thông tin tác giả